Updated
ChemedCHE · Healthcare
$528.05-1.07%
Market cap$6.9B
IndustryMedical Care Facilities
Chemed (CHE) Superinvestor holders
23 of the superinvestors we track hold Chemed (CHE) in their latest 13F filings, $1.1B in total.
Summary
The largest holder is Cliff Asness (AQR Capital Management), with $446M, 0.2% of the portfolio.
In their latest quarter: 5 opened a new position, 8 added, 9 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | 972,474 | $446M | 0.2% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 461,748 | $233M | 0.3% | Q3 2026 |
| Mark Donovan Boston Partners |
New position | 280,684 | $131M | 0.1% | Q2 2026 |
| Arrowstreet Capital | Added | 166,149 | $77M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 93,085 | $43M | 0.1% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Trimmed | 91,789 | $43M | 0.2% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 74,460 | $35M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 39,080 | $18M | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 24,481 | $11M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 22,325 | $10M | 0.0% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | 20,528 | $10M | 0.1% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 20,399 | $10M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 12,232 | $6M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 7,620 | $4M | 0.0% | Q3 2026 |
| Brandon Haley Holocene Advisors |
New position | 8,101 | $4M | 0.0% | Q2 2026 |
| Chuck Royce Royce Investment Partners |
New position | 6,071 | $3M | 0.0% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 6,160 | $3M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 5,391 | $3M | 0.0% | Q2 2026 |
| Louis Bacon Moore Capital Management |
Trimmed | 5,072 | $2M | 0.1% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 3,406 | $2M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 2,492 | $1M | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
New position | 1,932 | $899,810 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Held | 844 | $393,085 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 22 |
| Q1 2026 | 19 |
| Q4 2025 | 20 |
| Q3 2025 | 22 |
| Q2 2025 | 22 |
| Q1 2025 | 22 |
| Q4 2024 | 19 |
| Q3 2024 | 18 |
Questions about Chemed
Which superinvestors own Chemed?
23 of the superinvestors we track hold Chemed (CHE) in their latest 13F filings, $1.1B in total. Cliff Asness, Acadian, Mark Donovan, Arrowstreet Capital, Joel Greenblatt, David Vogel.
Who is the largest superinvestor holder of CHE?
The largest holder is Cliff Asness (AQR Capital Management), with $446M, 0.2% of the portfolio.
From Chemed's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.